{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T23:10:38Z","timestamp":1778713838154,"version":"3.51.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T00:00:00Z","timestamp":1775174400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Jiangsu Province Key R&D Plan Social Development Project","award":["BE2023774"],"award-info":[{"award-number":["BE2023774"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"DOI":"10.1186\/s12902-026-02229-7","type":"journal-article","created":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T05:25:56Z","timestamp":1775193956000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A practical tool for risk stratification: eGDR as a predictor of incident diabetic kidney disease"],"prefix":"10.1186","volume":"26","author":[{"given":"Yuanxin","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongmei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingda","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinliang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,3]]},"reference":[{"issue":"1 Suppl 1","key":"2229_CR1","first-page":"S239","volume":"48","author":"Chronic Kidney Disease and Risk Management","year":"2025","unstructured":"Chronic Kidney Disease and Risk Management. Standards of Care in Diabetes-2025. Diabetes Care. 2025;48(1 Suppl 1):S239\u201351.","journal-title":"Diabetes Care"},{"issue":"10225","key":"2229_CR2","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","volume":"395","author":"regional Global","year":"2020","unstructured":"Global regional, national burden of chronic kidney disease. 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020;395(10225):709\u201333.","journal-title":"Lancet"},{"issue":"4S","key":"2229_CR3","first-page":"S117","volume":"105","author":"KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease","year":"2024","unstructured":"KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int. 2024;105(4S):S117\u2013314.","journal-title":"Kidney Int"},{"issue":"1","key":"2229_CR4","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1093\/ndt\/gfs290","volume":"28","author":"S De Cosmo","year":"2012","unstructured":"De Cosmo S, Menzaghi C, Prudente S, Trischitta V. Role of insulin resistance in kidney dysfunction: insights into the mechanism and epidemiological evidence. Nephrol Dial Transpl. 2012;28(1):29\u201336.","journal-title":"Nephrol Dial Transpl"},{"key":"2229_CR5","doi-asserted-by":"crossref","unstructured":"Wang N, Zhang C. Oxidative stress: a culprit in the progression of diabetic kidney disease. Antioxidants (Basel). 2024;13(4).","DOI":"10.3390\/antiox13040455"},{"key":"2229_CR6","doi-asserted-by":"crossref","unstructured":"Dong Y, Tong Y. Lipid peroxidation in diabetic kidney disease: mechanism and natural solution. Int J Mol Sci. 2025;26(19).","DOI":"10.3390\/ijms26199764"},{"issue":"3","key":"2229_CR7","doi-asserted-by":"publisher","first-page":"278","DOI":"10.2337\/diacare.19.3.278","volume":"19","author":"D Elahi","year":"1996","unstructured":"Elahi D. In praise of the hyperglycemic clamp. A method for assessment of beta-cell sensitivity and insulin resistance. Diabetes Care. 1996;19(3):278\u201386.","journal-title":"Diabetes Care"},{"key":"2229_CR8","doi-asserted-by":"publisher","first-page":"1591677","DOI":"10.3389\/fendo.2025.1591677","volume":"16","author":"U Aliyu","year":"2025","unstructured":"Aliyu U, Toor SM, Abdalhakam I, Elrayess MA, Abou Samra AB, Albagha OME. Evaluating indices of insulin resistance and estimating the prevalence of insulin resistance in a large biobank cohort. Front Endocrinol (Lausanne). 2025;16:1591677.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"2229_CR9","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1186\/s12933-025-02940-0","volume":"24","author":"M-Y Tan","year":"2025","unstructured":"Tan M-Y, Jiang Z-N, Li Y-Q, Li Z-Y, Niu B. Association of estimated glucose disposition rate with aging acceleration and mortality risk in individuals with cardiovascular-kidney-metabolic syndrome: evidence from two large national population-based studies. Cardiovasc Diabetol. 2025;24(1):402.","journal-title":"Cardiovasc Diabetol"},{"issue":"7","key":"2229_CR10","doi-asserted-by":"publisher","first-page":"e70100","DOI":"10.1002\/dmrr.70100","volume":"41","author":"S Angelino","year":"2025","unstructured":"Angelino S, Monda A, Di Martino N, Caruso P, Longo M, Maio A, Barrasso M, Scappaticcio L, Bellastella G, Giugliano D, et al. Exploring Insulin Resistance in Adults With Type 1 Diabetes: The Role of the Estimated Glucose Disposal Rate and the Triglyceride Glucose Index. Diabetes Metab Res Rev. 2025;41(7):e70100.","journal-title":"Diabetes Metab Res Rev"},{"issue":"1","key":"2229_CR11","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s12933-021-01394-4","volume":"20","author":"A Zabala","year":"2021","unstructured":"Zabala A, Darsalia V, Lind M, Svensson A-M, Franz\u00e9n S, Eliasson B, Patrone C, Jonsson M, Nystr\u00f6m T. Estimated glucose disposal rate and risk of stroke and mortality in type 2 diabetes: a nationwide cohort study. Cardiovasc Diabetol. 2021;20(1):202.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2229_CR12","doi-asserted-by":"publisher","first-page":"38060","DOI":"10.1038\/s41598-025-21850-5","volume":"15","author":"H Wang","year":"2025","unstructured":"Wang H, Zhang H, Zhang L, Zheng X, Yang M. Combined effects of insulin resistance and dyslipidaemia on cardiometabolic multimorbidity in Chinese middle-age and older adults: a longitudinal cohort study. Sci Rep. 2025;15(1):38060.","journal-title":"Sci Rep"},{"issue":"1","key":"2229_CR13","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12933-023-01791-x","volume":"22","author":"W Linn","year":"2023","unstructured":"Linn W, Persson M, Rathsman B, Ludvigsson J, Lind M, Andersson Franko M, Nystr\u00f6m T. Estimated glucose disposal rate is associated with retinopathy and kidney disease in young people with type 1 diabetes: a nationwide observational study. Cardiovasc Diabetol. 2023;22(1):61.","journal-title":"Cardiovasc Diabetol"},{"key":"2229_CR14","doi-asserted-by":"publisher","first-page":"1507735","DOI":"10.3389\/fendo.2025.1507735","volume":"16","author":"Y Liu","year":"2025","unstructured":"Liu Y, Liu M, Jiang Y, Cui S, Tang W. Association of estimated glucose disposal rate with chronic kidney disease: comparative analysis against traditional insulin resistance indices. Front Endocrinol (Lausanne). 2025;16:1507735.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"7","key":"2229_CR15","doi-asserted-by":"publisher","first-page":"bvad069","DOI":"10.1210\/jendso\/bvad069","volume":"7","author":"J Peng","year":"2023","unstructured":"Peng J, Li A, Yin L, Yang Q, Pan J, Yi B. Estimated Glucose Disposal Rate Predicts Renal Progression in Type 2 Diabetes Mellitus: A Retrospective Cohort Study. J Endocr Soc. 2023;7(7):bvad069.","journal-title":"J Endocr Soc"},{"issue":"9","key":"2229_CR16","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604\u201312.","journal-title":"Ann Intern Med"},{"key":"2229_CR17","doi-asserted-by":"crossref","unstructured":"Nakashima A, Kato K, Ohkido I, Yokoo T. Role and treatment of insulin resistance in patients with chronic kidney disease: a review. Nutrients. 2021;13(12).","DOI":"10.3390\/nu13124349"},{"issue":"4","key":"2229_CR18","doi-asserted-by":"publisher","first-page":"5069","DOI":"10.1002\/j.2040-4603.2023.tb00281.x","volume":"13","author":"VP Parvathareddy","year":"2023","unstructured":"Parvathareddy VP, Wu J, Thomas SS. Insulin Resistance and Insulin Handling in Chronic Kidney Disease. Compr Physiol. 2023;13(4):5069\u201376.","journal-title":"Compr Physiol"},{"issue":"1","key":"2229_CR19","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s12933-025-02729-1","volume":"24","author":"B Dong","year":"2025","unstructured":"Dong B, Chen Y, Yang X, Chen Z, Zhang H, Gao Y, Zhao E, Zhang C. Estimated glucose disposal rate outperforms other insulin resistance surrogates in predicting incident cardiovascular diseases in cardiovascular-kidney-metabolic syndrome stages 0\u20133 and the development of a machine learning prediction model: a nationwide prospective cohort study. Cardiovasc Diabetol. 2025;24(1):163.","journal-title":"Cardiovasc Diabetol"},{"key":"2229_CR20","doi-asserted-by":"publisher","first-page":"04249","DOI":"10.7189\/jogh.15.04249","volume":"15","author":"X Chen","year":"2025","unstructured":"Chen X, Du L, Peng J. Association between estimated glucose disposal rate and cardiovascular disease prevalence and mortality outcomes in metabolic dysfunction-associated steatotic liver disease: a comparative analysis of insulin resistance markers. J Glob Health. 2025;15:04249.","journal-title":"J Glob Health"},{"issue":"2","key":"2229_CR21","doi-asserted-by":"publisher","first-page":"e70037","DOI":"10.1002\/edm2.70037","volume":"8","author":"E Bahrami Hezaveh","year":"2025","unstructured":"Bahrami Hezaveh E, Hashemi R, Noorafrooz M, Mohammadi F, Yadegar A, Karimpour Reyhan S, Nakhjavani M, Esteghamati A, Rabizadeh S. Estimated Glucose Disposal Rate: A Potential Determinant for Microvascular and Macrovascular Complications in Type 2 Diabetes. Endocrinol Diabetes Metab. 2025;8(2):e70037.","journal-title":"Endocrinol Diabetes Metab"},{"key":"2229_CR22","doi-asserted-by":"crossref","unstructured":"Zhang F, Li J, Li X, Huang L, Zhong Y. Association of baseline and changes in estimated glucose disposal rate and risk of chronic kidney disease: evidence from a national longitudinal study. Acta Diabetol. 2025.","DOI":"10.1007\/s00592-025-02528-w"},{"key":"2229_CR23","doi-asserted-by":"crossref","unstructured":"Kuma A, Kato A. Lifestyle-related risk factors for the incidence and progression of chronic kidney disease in the healthy young and middle-aged population. Nutrients. 2022;14(18).","DOI":"10.3390\/nu14183787"},{"key":"2229_CR24","doi-asserted-by":"crossref","unstructured":"Jha R, Lopez-Trevino S, Kankanamalage HR, Jha JC. Diabetes and renal complications: an overview on pathophysiology, biomarkers and therapeutic interventions. Biomedicines. 2024;12(5).","DOI":"10.3390\/biomedicines12051098"},{"issue":"18","key":"2229_CR25","doi-asserted-by":"publisher","first-page":"2875","DOI":"10.1093\/cvr\/cvad190","volume":"119","author":"A Elwakiel","year":"2024","unstructured":"Elwakiel A, Mathew A, Isermann B. The role of endoplasmic reticulum-mitochondria-associated membranes in diabetic kidney disease. Cardiovasc Res. 2024;119(18):2875\u201383.","journal-title":"Cardiovasc Res"},{"issue":"4","key":"2229_CR26","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1002\/2211-5463.12400","volume":"8","author":"A Mima","year":"2018","unstructured":"Mima A, Yasuzawa T, King GL, Ueshima S. Obesity-associated glomerular inflammation increases albuminuria without renal histological changes. FEBS Open Bio. 2018;8(4):664\u201370.","journal-title":"FEBS Open Bio"},{"issue":"8","key":"2229_CR27","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1038\/ki.2010.526","volume":"79","author":"A Mima","year":"2011","unstructured":"Mima A, Ohshiro Y, Kitada M, Matsumoto M, Geraldes P, Li C, Li Q, White GS, Cahill C, Rask-Madsen C, et al. Glomerular-specific protein kinase C-\u03b2-induced insulin receptor substrate-1 dysfunction and insulin resistance in rat models of diabetes and obesity. Kidney Int. 2011;79(8):883\u201396.","journal-title":"Kidney Int"},{"key":"2229_CR28","doi-asserted-by":"publisher","first-page":"100236","DOI":"10.1016\/j.metop.2023.100236","volume":"17","author":"A Mima","year":"2023","unstructured":"Mima A, Gotoda H, Lee R, Murakami A, Akai R, Lee S. Effects of incretin-based therapeutic agents including tirzepatide on renal outcomes in patients with type 2 diabetes: A systemic review and meta-analysis. Metabol Open. 2023;17:100236.","journal-title":"Metabol Open"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-026-02229-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-026-02229-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-026-02229-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T22:34:17Z","timestamp":1778711657000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12902-026-02229-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,3]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2229"],"URL":"https:\/\/doi.org\/10.1186\/s12902-026-02229-7","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,3]]},"assertion":[{"value":"20 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Geriatric Hospital of Nanjing Medical University (approval number: 2025 121-1). As this was a retrospective analysis of de-identified clinical data, the requirement for informed consent was waived by the Ethics Committee. All procedures were conducted in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"140"}}